Home |  Contact Us | Site Map

Latest News

All Releases
View Summary FDA Grants Fast Track Designation for BCX4161 for the Treatment of Hereditary Angioedema
Jan 26, 2015
PDF 20.8 KB
View Summary BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema
Jan 14, 2015
PDF 20.8 KB
View Summary BioCryst to Present at J.P. Morgan Healthcare Conference
Jan 6, 2015
PDF 15.2 KB
View Summary BioCryst Pharmaceuticals Announces the Appointment of Lynne Powell as Chief Commercial Officer
Jan 5, 2015
PDF 17.2 KB
View Summary BioCryst Receives Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema
Dec 23, 2014
PDF 19.5 KB
View Summary BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection
Dec 23, 2014
PDF 19.3 KB
View Summary BioCryst's RAPIVAB(TM) (peramivir injection) Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza
Dec 22, 2014
PDF 19.2 KB
View Summary BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema
Dec 18, 2014
PDF 20.5 KB
View Summary BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses
Dec 15, 2014
PDF 17.6 KB
View Summary BioCryst to Present at Two Upcoming Investor Conferences
Nov 20, 2014
PDF 15.4 KB
View Summary BioCryst Reports Third Quarter 2014 Financial Results
Nov 6, 2014
PDF 30.3 KB
View Summary BioCryst to Announce Third Quarter 2014 Financial Results November 6
Oct 30, 2014
PDF 16.3 KB
View Summary RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014
Oct 8, 2014
PDF 18.0 KB
View Summary BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress
Oct 7, 2014
PDF 61.6 KB
View Summary BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases
Sep 18, 2014
PDF 20.9 KB
View Summary BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting
Sep 6, 2014
PDF 18.7 KB
View Summary BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies
Sep 4, 2014
PDF 18.0 KB
View Summary BioCryst to Present at Rodman & Renshaw Conference
Sep 3, 2014
PDF 15.0 KB
View Summary BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting
Sep 2, 2014
PDF 18.1 KB
View Summary BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease
Aug 29, 2014
PDF 17.3 KB
Showing 1-20 of 143 Page: 1 2 3 ... 8  Next 20